MedPath

海南紫程众投生物科技有限公司

Ownership
-
Established
2021-03-10
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20254380
Approval Date
May 27, 2025
NMPA

Mupirocin Ointment

Product Name
莫匹罗星软膏
Approval Number
国药准字H20254083
Approval Date
May 13, 2025
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20253354
Approval Date
Feb 8, 2025
NMPA

Lidocaine And Prilocaine Cream

Product Name
利丙双卡因乳膏
Approval Number
国药准字H20249685
Approval Date
Dec 6, 2024
NMPA

Roxatidine Acetate Hydrochloride for Injection

Product Name
注射用盐酸罗沙替丁醋酸酯
Approval Number
国药准字H20243848
Approval Date
May 28, 2024
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20243188
Approval Date
Feb 20, 2024
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20234404
Approval Date
Jan 10, 2024
NMPA

Calcium Gluconate and Sodium Chloride Injection

Product Name
葡萄糖酸钙氯化钠注射液
Approval Number
国药准字H20234405
Approval Date
Jan 10, 2024
NMPA

Aminophylline Injection

Product Name
氨茶碱注射液
Approval Number
国药准字H51023215
Approval Date
Dec 2, 2020
NMPA

Aminophylline Injection

Product Name
氨茶碱注射液
Approval Number
国药准字H20067459
Approval Date
Aug 5, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.